Colorectal cancer Posts - Page 44 of 68 on Medivizor
Navigation Menu

Colorectal cancer Posts on Medivizor

Treatment options for patients with colorectal cancer that has spread to the peritoneum

Treatment options for patients with colorectal cancer that has spread to the peritoneum

Posted by on Feb 15, 2015 in Colorectal cancer | 0 comments

In a nutshell This study investigated two treatment options for patients with cancer that has spread to the peritoneum (the lining of the abdominal cavity). Some background A common location for colorectal cancer to spread is the peritoneum. The best way to treat patients with peritoneal invasion is with cytoreductive surgery plus intraperitoneal...

Read More

Which colon cancer surgery is safest when lymph nodes are also being removed?

Which colon cancer surgery is safest when lymph nodes are also being removed?

Posted by on Feb 15, 2015 in Colorectal cancer | 0 comments

In a nutshell This study investigated which surgical technique for colon cancer is safest when lymph nodes are also being dissected. Some background The two main surgeries for treating colon cancer are open surgery and laparoscopic surgery. Open surgery is the original technique involving a large incision to remove part of the bowel. Laparoscopic...

Read More

miR-21; a tiny messenger that can help predict colorectal cancer relapse

miR-21; a tiny messenger that can help predict colorectal cancer relapse

Posted by on Feb 15, 2015 in Colorectal cancer | 0 comments

In a nutshell This study investigated if miR-21 levels can predict cancer relapse in colorectal cancer patients. Some background MicroRNA’s are small messengers that help regulate the levels of genes. Recent studies have shown that one particular microRNA, miR-21, is associated with the progression of some cancers. Certain proteins produced...

Read More

No cancer in the lymph nodes is linked to low rates of local recurrence in rectal cancer patients

No cancer in the lymph nodes is linked to low rates of local recurrence in rectal cancer patients

Posted by on Feb 9, 2015 in Colorectal cancer | 0 comments

In a nutshell This study investigated the rates of cancer return in patients with locally advanced rectal cancer that had not spread to lymph nodes, and whether any factors were linked to increased rates of cancer return. Some background Locally advanced rectal cancer indicates that the cancer has spread beyond the lining of the rectum, or has...

Read More

Anastomotic leakage in rectal cancer patients: a major surgical complication but not a major long-term risk factor

Anastomotic leakage in rectal cancer patients: a major surgical complication but not a major long-term risk factor

Posted by on Feb 9, 2015 in Colorectal cancer | 0 comments

In a nutshell This study investigated the impact of anastomotic leakage, a major surgical complication, on the risk for rectal cancer returning. Some background The main treatment option for patients with rectal cancer is surgery. One major complication that can occur after surgery is anastomotic leakage. Generally this involves the leakage of...

Read More

Standard treatment for locally advanced rectal cancer: some concerns remain

Standard treatment for locally advanced rectal cancer: some concerns remain

Posted by on Feb 9, 2015 in Colorectal cancer | 0 comments

In a nutshell This review highlights the existing concerns facing treatment of locally advanced rectal cancer patients with preoperative chemotherapy. Some background Locally advanced rectal cancer indicates that the cancer has spread beyond the lining of the rectum or has spread to the nearby lymph nodes. Preoperative chemoradiotherapy (PCRT;...

Read More

Does bevacizumab increase the risk of surgical complications for rectal cancer patients?

Posted by on Feb 2, 2015 in Colorectal cancer | 0 comments

In a nutshell This study analyzed whether the drug bevacizumab is linked with increased rates of surgical complications. Some background In locally advanced rectal cancer the cancer has spread beyond the lining of the rectum or has spread to the nearby lymph nodes. The standard treatment for patients with locally advanced rectal cancer is...

Read More

Over 70? Bevacizumab is safe and effective for treating metastatic colorectal cancer

Over 70? Bevacizumab is safe and effective for treating metastatic colorectal cancer

Posted by on Feb 2, 2015 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the safety and efficacy of bevacizumab (Avastin) in patients with metastatic colorectal cancer aged 70 and above versus younger patients. Some background Bevacizumab is a new biologic therapy (a medicine extracted from biological sources e.g. produced by cell lines) for cancer treatment. It works by blocking the...

Read More

An invitation to take part in a study measuring the impact of a physical activity program on colon cancer progression

An invitation to take part in a study measuring the impact of a physical activity program on colon cancer progression

Posted by on Feb 2, 2015 in Colorectal cancer | 0 comments

In a nutshell The aim of this trial will be to determine whether participating in a physical activity program, along with health education, is more effective at decreasing colorectal cancer recurrence than health education alone. The primary outcome measured in this trial will be disease-free survival (how long following treatment a patient remains...

Read More

New treatment plan might improve the outcome of advanced colorectal cancer patients

New treatment plan might improve the outcome of advanced colorectal cancer patients

Posted by on Feb 1, 2015 in Colorectal cancer | 0 comments

In a nutshell This study evaluated how cetuximab (Erbitux) might be safely and effectively added to intermittent (a planned interruption in the treatment) chemotherapy regimens. Some background Advanced colorectal cancer is treated with a combination of cytotoxic drugs and novel treatments. Cytotoxic drugs, including chemotherapy, work by killing...

Read More